The FDA is warning patients and referrers about an imaging business near the nation’s capital that has fumbled away its mammography accreditation.

One of the largest private health insurers in the U.S. has gone from considering hybrid PET/CT for cardiac indications “experimental/investigational” to displaying willingness to pay for the modality. 

A convolutional neural network has achieved 99.67% accuracy at flagging the presence of pacemakers on chest radiographs in patients referred for MRI.

The protocol does not come at the expense of deteriorated image quality, according to work published recently in the European Journal of Radiology.

The new meta-analysis included data from nearly 10,000 patients. 

This week Bayer announced the launch of Calantic Digital Solutions, a suite of applications intended to optimize clinical workflows by triaging and prioritizing critical findings, improving disease detection and automating tasks for radiologists. 

“More than most companies, Toyota is led from the bottom up as much as from the top down.”

A cancer-care technology company that was acquired by one of the world’s largest imaging OEMs a year ago has received an Investigational Device Exemption from the FDA.